INVIVYD INC (IVVD) — insider trading
Health Care · NASDAQ
INVIVYD INC (IVVD) has 50 reported SEC Form 4 insider transactions in our data, including 20 open-market sales among the most recent 50 (latest 2026-08-31).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Sheffield Ian | Director | Grant / award / vesting (derivative) | 100,000 | — | $0 | Form 4 |
| 2026-08-30 | Elia Marc | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 10,700,000 | — | $0 | Form 4 |
| 2026-08-18 | Allen Robert D. III | Officer (Chief Scientific Officer) | Open-market sale | 17,043 | $0.8429 | $14.4K | Form 4 |
| 2026-08-18 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Open-market sale | 30,706 | $0.8429 | $25.9K | Form 4 |
| 2026-08-18 | Duke William E. | Officer (Chief Financial Officer) | Open-market sale | 18,425 | $0.8429 | $15.5K | Form 4 |
| 2026-08-18 | Green Julie | Officer (Chief Human Resources Officer) | Open-market sale | 18,425 | $0.8429 | $15.5K | Form 4 |
| 2026-08-18 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Open-market sale | 18,425 | $0.8429 | $15.5K | Form 4 |
| 2026-08-17 | Allen Robert D. III | Officer (Chief Scientific Officer) | Open-market sale | 20,679 | $0.722 | $14.9K | Form 4 |
| 2026-08-17 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Open-market sale | 37,256 | $0.722 | $26.9K | Form 4 |
| 2026-08-17 | Duke William E. | Officer (Chief Financial Officer) | Open-market sale | 22,355 | $0.722 | $16.1K | Form 4 |
| 2026-08-17 | Green Julie | Officer (Chief Human Resources Officer) | Open-market sale | 22,355 | $0.722 | $16.1K | Form 4 |
| 2026-08-17 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Open-market sale | 22,355 | $0.722 | $16.1K | Form 4 |
| 2026-08-15 | Allen Robert D. III | Officer (Chief Scientific Officer) | Option exercise / conversion (derivative) | 102,000 | — | $0 | Form 4 |
| 2026-08-15 | Allen Robert D. III | Officer (Chief Scientific Officer) | Option exercise / conversion | 102,000 | — | — | Form 4 |
| 2026-08-15 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Option exercise / conversion (derivative) | 170,000 | — | $0 | Form 4 |
| 2026-08-15 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Option exercise / conversion | 170,000 | — | — | Form 4 |
| 2026-08-15 | Duke William E. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 102,000 | — | $0 | Form 4 |
| 2026-08-15 | Duke William E. | Officer (Chief Financial Officer) | Option exercise / conversion | 102,000 | — | — | Form 4 |
| 2026-08-15 | Green Julie | Officer (Chief Human Resources Officer) | Option exercise / conversion (derivative) | 102,000 | — | $0 | Form 4 |
| 2026-08-15 | Green Julie | Officer (Chief Human Resources Officer) | Option exercise / conversion | 102,000 | — | — | Form 4 |
| 2026-08-15 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 102,000 | — | $0 | Form 4 |
| 2026-08-15 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Option exercise / conversion | 102,000 | — | — | Form 4 |
| 2026-07-31 | Mina Michael | Officer (CMO and Chief Epidemiologist) | Grant / award / vesting (derivative) | 1,125,000 | — | $0 | Form 4 |
| 2026-05-19 | Berry Tamsin | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-05-19 | BOLNO PAUL | Director | Grant / award / vesting (derivative) | 32,876 | — | $0 | Form 4 |
| 2026-05-19 | Elia Marc; M28 Capital Management LP | Director, Other | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-05-19 | MCGUIRE TERRANCE | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-05-19 | MCLAUGHLIN KEVIN F | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-05-19 | Royan Ajay | Director | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-02-18 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Open-market sale | 34,939 | $1.58 | $55.1K | Form 4 |
| 2026-02-18 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Open-market sale | 20,964 | $1.58 | $33.1K | Form 4 |
| 2026-02-18 | Duke William E. | Officer (Chief Financial Officer) | Open-market sale | 20,964 | $1.58 | $33.1K | Form 4 |
| 2026-02-18 | Green Julie | Officer (Chief Human Resources Officer) | Open-market sale | 20,964 | $1.58 | $33.1K | Form 4 |
| 2026-02-18 | Allen Robert D. III | Officer (Chief Scientific Officer) | Open-market sale | 19,392 | $1.58 | $30.6K | Form 4 |
| 2026-02-17 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Open-market sale | 32,771 | $1.54 | $50.5K | Form 4 |
| 2026-02-17 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Open-market sale | 19,663 | $1.54 | $30.3K | Form 4 |
| 2026-02-17 | Duke William E. | Officer (Chief Financial Officer) | Open-market sale | 19,663 | $1.54 | $30.3K | Form 4 |
| 2026-02-17 | Green Julie | Officer (Chief Human Resources Officer) | Open-market sale | 19,663 | $1.54 | $30.3K | Form 4 |
| 2026-02-17 | Allen Robert D. III | Officer (Chief Scientific Officer) | Open-market sale | 18,189 | $1.54 | $28.0K | Form 4 |
| 2026-02-15 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Option exercise / conversion (derivative) | 165,000 | — | $0 | Form 4 |
| 2026-02-15 | Andersen Jill | Officer (Chief Legal Officer, Secretary) | Option exercise / conversion | 165,000 | — | — | Form 4 |
| 2026-02-15 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 99,000 | — | $0 | Form 4 |
| 2026-02-15 | Lee Timothy Edward | Officer (Chief Commercial Officer) | Option exercise / conversion | 99,000 | — | — | Form 4 |
| 2026-02-15 | Duke William E. | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 99,000 | — | $0 | Form 4 |
| 2026-02-15 | Duke William E. | Officer (Chief Financial Officer) | Option exercise / conversion | 99,000 | — | — | Form 4 |
| 2026-02-15 | Green Julie | Officer (Chief Human Resources Officer) | Option exercise / conversion (derivative) | 99,000 | — | $0 | Form 4 |
| 2026-02-15 | Green Julie | Officer (Chief Human Resources Officer) | Option exercise / conversion | 99,000 | — | — | Form 4 |
| 2026-02-15 | Allen Robert D. III | Officer (Chief Scientific Officer) | Option exercise / conversion (derivative) | 99,000 | — | $0 | Form 4 |
| 2026-02-15 | Allen Robert D. III | Officer (Chief Scientific Officer) | Option exercise / conversion | 99,000 | — | — | Form 4 |
| 2026-01-29 | Duke William E. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 625,000 | — | $0 | Form 4 |
Ask the chat about IVVD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: INVIVYD INC (IVVD).
Last updated 2026-08-31 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.